Showing results (1681-1690 of 2,286) with videos related to
Sort By:
Pageof 229
Journal of Neuro-Oncology|July 8, 2011
A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant gliomaAnnick Desjardins, David A Reardon, Katherine B Peters, et al.Investigative Ophthalmology & Visual Science|September 8, 2011
Prevalence of primary open angle glaucoma in a rural adult Chinese population: the Handan eye studyYuan Bo Liang, David S Friedman, Qiang Zhou, et al.Public Health Reports (Washington, D.C. : 1974)|April 8, 2021
Using the Electronic Health Record to Characterize the Hepatitis C Virus Care CascadeShannon M Christy, Richard R Reich, Julie A Rathwell, et al.Ophthalmology|July 3, 2020
Patterns of Daily Physical Activity across the Spectrum of Visual Field Damage in Glaucoma PatientsJian-Yu E, Jennifer A Schrack, Aleksandra Mihailovic, et al.Ophthalmology|November 8, 2025
Long-term Persistent Angle Closure and Anatomic Changes after Laser Iridotomy in Suspected Primary Angle-ClosureAndrea Servillo, Tin A Tun, Chungkwon Yoo, et al.Royal Society Open Science|August 8, 2024
High infectivity and waterborne transmission of seagrass wasting diseaseMorgan E Eisenlord, M Victoria Agnew, Miranda Winningham, et al.The Oncologist|May 31, 2015
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable GlioblastomaKatherine B Peters, Emil Lou, Annick Desjardins, et al.Neuro-Oncology|March 27, 2001
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II studyD H Mahoney, M E Cohen, H S Friedman, et al.Neurology|January 1, 1989
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumorH S Friedman, S C Schold, W T Djang, et al.Ophthalmology Science|October 17, 2022
Assessing Surface Shapes of the Optic Nerve Head and Peripapillary Retinal Nerve Fiber Layer in Glaucoma with Artificial IntelligenceChhavi Saini, Lucy Q Shen, Louis R Pasquale, et al.Pageof 229